MTF1 and ovarian carcinoma: Similar findings were observed in the ovarian cancer cell line HEY, where reconstitution with MTF1 S152A mutant, but not the S152D mutant, significantly rescued MTF1 KO HEY cell viability (Fig. 3I and J) and xenograft tumor growth (Fig. 3K and L) under cisplatin treatment.